Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain

Adrián Bravo-Gómez, Sara Salvador‐Martín, Paula Zapata-Cobo, María Sanjurjo‐Sáez, Luis A. López‐Fernández

Pharmaceutics · 2022 · 12 citations · 11 references

DOIFull text

Open access

Abstract

Genotyping of rs887829 using the proposed method may be used to substitute genotyping of rs34983651 as a pharmacogenetics test in cancer patients prior to starting irinotecan-based treatments, mainly in the Iberian population. In addition, it is less expensive than other conventional methods and easy to implement, with a shorter time to decision than <i>UGT1A1</i>*28.

References

11